BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Federico A, Gravina AG, Miranda A, Loguercio C, Romano M. Eradication of Helicobacter pylori infection: Which regimen first? World J Gastroenterol 2014; 20(3): 665-672 [PMID: 24574740 DOI: 10.3748/wjg.v20.i3.665]
URL: https://www.wjgnet.com/1007-9327/full/v20/i3/665.htm
Number Citing Articles
1
Breno Bittencourt de Brito, Filipe Antônio França da Silva, Aline Silva Soares, Vinícius Afonso Pereira, Maria Luísa Cordeiro Santos, Mariana Miranda Sampaio, Pedro Henrique Moreira Neves, Fabrício Freire de Melo. Pathogenesis and clinical management of <i>Helicobacter pylori</i> gastric infectionWorld Journal of Gastroenterology 2019; 25(37): 5578-5589 doi: 10.3748/wjg.v25.i37.5578
2
Ju Yup Lee, Kyung Sik Park. Optimal First-Line Treatment forHelicobacter pyloriInfection: Recent StrategiesGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/9086581
3
Jing Su, Xiaoying Zhou, Han Chen, Bo Hao, Weifeng Zhang, Guoxin Zhang. Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infectionMedicine 2017; 96(7): e5859 doi: 10.1097/MD.0000000000005859
4
Huseyin Alkim, Ali Riza Koksal, Salih Boga, Ilker Sen, Canan Alkim. Role of Bismuth in the Eradication of Helicobacter pyloriAmerican Journal of Therapeutics 2017; 24(6): e751 doi: 10.1097/MJT.0000000000000389
5
Kazunori Adachi, Shunsuke Kato, Akira Koshino, Kazuhiro Nagao, Tomoya Sugiyama, Takashi Yoshimine, Yoshiharu Yamaguchi, Shinya Izawa, Wataru Ohashi, Masahide Ebi, Yasushi Funaki, Naotaka Ogasawara, Makoto Sasaki, Kunio Kasugai. A Vonoprazan, Clarithromycin, and Metronidazole Regimen as <i>Helicobacter pylori</i> Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin ResistanceInternal Medicine 2023; 62(16): 2301 doi: 10.2169/internalmedicine.0789-22
6
Jai‑Sing Yang, Chao‑Min Wang, Chiu‑Hsian Su, Han‑Chen Ho, Chiung‑Hung Chang, Chang‑Hung Chou, Yuan‑Man Hsu. Eudesmin attenuates Helicobacter�pylori-induced epithelial autophagy and apoptosis and leads to eradication of H. pylori infectionExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.5701
7
Thomas A. VanDruff. Management of Select ThrombocytopeniasAACN Advanced Critical Care 2019; 30(2): 165 doi: 10.4037/aacnacc2019186
8
Ryusuke Horie, Osamu Handa, Takashi Ando, Takuya Ose, Takaaki Murakami, Norihisa Suzuki, Rei Sendo, Eiko Imamoto, Yoshito Itoh. Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in JapanHelicobacter 2020; 25(4) doi: 10.1111/hel.12698
9
Pramodini B. Kale‐Pradhan, Anela Mihaescu, Sheila M. Wilhelm. Fluoroquinolone Sequential Therapy for Helicobacter pylori: A Meta‐analysisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2015; 35(8): 719 doi: 10.1002/phar.1614
10
Cristina Maria Marginean, Ramona Cioboata, Mihai Olteanu, Corina Maria Vasile, Mihaela Popescu, Alin Iulian Silviu Popescu, Simona Bondari, Denisa Pirscoveanu, Iulia Cristina Marginean, George Alexandru Iacob, Mihai Daniel Popescu, Mihaela Stanciu, Paul Mitrut. The Importance of Accurate Early Diagnosis and Eradication in Helicobacter pylori Infection: Pictorial Summary Review in Children and AdultsAntibiotics 2022; 12(1): 60 doi: 10.3390/antibiotics12010060
11
Manuel Pabón‐Carrasco, Alma Keco‐Huerga, Manuel Castro‐Fernández, Ilaria Maria Saracino, Giulia Fiorini, Dino Vaira, Ángeles Pérez‐Aísa, Bojan Tepes, Laimas Jonaitis, Irina Voynovan, Alfredo J. Lucendo, Ángel Lanas, Samuel J. Martínez‐Domínguez, Enrique Alfaro Almajano, Luis Rodrigo, Ludmila Vologzanina, Natasa Brglez Jurecic, Maja Denkovski, Luis Bujanda, Rustam A. Abdulkhakov, Jose M. Huguet, Luis Fernández‐Salazar, Noelia Alcaide, Benito Velayos, Aiman Silkanovna Sarsenbaeva, Oleg Zaytsev, Tatiana Ilchishina, Jesús Barrio, Igor Bakulin, Monica Perona, Sergey Alekseenko, Marco Romano, Antonietta G. Gravina, Óscar Núñez, Blas José Gómez Rodríguez, Diego Ledro‐Cano, Rinaldo Pellicano, Pavel Bogomolov, Manuel Domínguez‐Cajal, Pedro Almela, Judith Gomez‐Camarero, Dmitry S. Bordin, Antonio Gasbarrini, Juozas Kupčinskas, Anna Cano‐Català, Leticia Moreira, Olga P. Nyssen, Francis Mégraud, Colm O’Morain, Javier P. Gisbert. Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori managementUnited European Gastroenterology Journal 2024; 12(1): 122 doi: 10.1002/ueg2.12476
12
Antonio Cuadrado-Lavín, J. Ramón Salcines-Caviedes, Ainhoa Diaz-Perez, Miguel F. Carrascosa, María Ochagavía, José Luis Fernandez-Forcelledo, Marta Cobo, Pedro Fernández-Gil, Blanca Ayestarán, Blanca Sánchez, Cristina Campo, Javier Llorca, Silvia Lorenzo, Aitziber Illaro. First-line eradication rates comparing two shortened non-bismuth quadruple regimens against Helicobacter pylori: an open-label, randomized, multicentre clinical trialJournal of Antimicrobial Chemotherapy 2015; 70(8): 2376 doi: 10.1093/jac/dkv089
13
Rocco Maurizio Zagari, Marco Romano, Veronica Ojetti, Reinhold Stockbrugger, Sergio Gullini, Bruno Annibale, Fabio Farinati, Enzo Ierardi, Giovanni Maconi, Massimo Rugge, Carlo Calabrese, Francesco Di Mario, Francesco Luzza, Stefano Pretolani, Antonella Savio, Giovanni Gasbarrini, Michele Caselli. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015Digestive and Liver Disease 2015; 47(11): 903 doi: 10.1016/j.dld.2015.06.010
14
Kokab Namkin, Mahmood Zardast, Fatemeh Basirinejad. Saccharomyces Boulardii in Helicobacter Pylori Eradication in Children: A Randomized Trial From IranIranian Journal of Pediatrics 2016; 26(1) doi: 10.5812/ijp.3768
15
Ying-Ying Han, Lin Zhou, Yun-Lian Hu, Xiang-Wu Ding, Hui Long, Fei Liu, Ming Xu, Zhen-Yu Zhang, Shuang-Ling Li, Qiu-Yan Wang, Cheng-Xia Su, Yan Chen, Jie Chen, Ya Lin, Pei-Yuan Li. Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled studyJournal of Gastroenterology 2023; 58(12): 1167 doi: 10.1007/s00535-023-02042-2
16
Phoebe Aitila, Michael Mutyaba, Simon Okeny, Maurice Ndawula Kasule, Rashid Kasule, Frank Ssedyabane, Benson Okongo, Richard Onyuthi Apecu, Enoch Muwanguzi, Caesar Oyet. Prevalence and Risk Factors ofHelicobacter pyloriInfection among Children Aged 1 to 15 Years at Holy Innocents Children’s Hospital, Mbarara, South Western UgandaJournal of Tropical Medicine 2019; 2019: 1 doi: 10.1155/2019/9303072
17
Frank J Senatore, Jonathan Wilmot, John W Birk. Helicobacter pyloritreatment: Still a work in progressPostgraduate Medicine 2016; 128(1): 152 doi: 10.1080/00325481.2016.1103194
18
Irineu Dos Santos Viana, Maria Luísa Cordeiro Santos, Hanna Santos Marques, Vinícius Lima de Souza Gonçalves, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Natália Oliveira e Silva, Fillipe Dantas Pinheiro, Adriano Fernandes Teixeira, Davi Tanajura Costa, Briza Oliveira Souza, Cláudio Lima Souza, Márcio Vasconcelos Oliveira, Fabrício Freire de Melo. Vaccine development against Helicobacter pylori: from ideal antigens to the current landscapeExpert Review of Vaccines 2021; 20(8): 989 doi: 10.1080/14760584.2021.1945450
19
Xiaohua Hou, Fandong Meng, Jiangbin Wang, Weihong Sha, Cheng‐Tang Chiu, Woo Chul Chung, Liqun Gu, Kentarou Kudou, Chui Fung Chong, Shutian Zhang. Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patientsJournal of Gastroenterology and Hepatology 2022; 37(7): 1275 doi: 10.1111/jgh.15837
20
Yuuichi Sakurai, Madoka Shiino, Hiroyuki Okamoto, Akira Nishimura, Koki Nakamura, Setsuo Hasegawa. Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover StudyAdvances in Therapy 2016; 33(9): 1519 doi: 10.1007/s12325-016-0374-x
21
Ethel Zimberg  Chehter. Helicobacter Pylori Treatment with Alternative Drugs: Good and Cheap for Developing Countries Furazolidone-Based Treatment- Omeprazole, Furazolidone and Tetracycline Open-Label Trial in A Developing Country: Why Not?Gastroenterology & Hepatology: Open Access 2014; 1(2) doi: 10.15406/ghoa.2014.01.00011
22
Rosalie Allison, Donna M. Lecky, Megan Bull, Kim Turner, Gauri Godbole, Cliodna A. M. McNulty. Audit ofHelicobacter pyloriTesting in Microbiology Laboratories in England: To Inform Compliance with NICE Guidance and the Feasibility of Routine Antimicrobial Resistance SurveillanceInternational Journal of Microbiology 2016; 2016: 1 doi: 10.1155/2016/8540904